News
Featured
Recent news
)
Oxford Nanopore strengthens executive leadership team
)
London Calling 2026 Technology Update
)
Lonza and Oxford Nanopore Technologies Launch Direct RNA Sequencing Solution for GMP mRNA Quality Control
)
Compatible ecosystem growth accelerates across oncology, pathogen and multi‑omics workflows
)
Werfen and Oxford Nanopore enter strategic collaboration to support development of advanced transplant assays
)
Action for ME announces research study for ME and Long Covid
)
Cepheid and Oxford Nanopore expand partnership following successful phase one collaboration
Oxford Nanopore and A.D.A.M. Innovations announce international collaboration to accelerate advanced genomic medicine in Japan
)
ViruSure launches first GMP-validated viral safety test based on Oxford Nanopore sequencing
)
Oxford Nanopore receives regulatory approval for its first diagnostic device in the UK and Europe
Appointment of Francis Van Parys as Chief Executive Officer
)
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterise drug resistant-tuberculosis
Most read
- pioneering european collaboration to advance genetic diagnostics introducing the european long read innovation network elrin
- news r103 newest nanopore high accuracy nanopore sequencing now available store
- london calling 2025 technology update
- news blog you cant put label innovation or can you
- breakthrough towards protein sequencing using oxford nanopore holds promise for disease research and drug development


)